CAS 10242-09-8

2-Benzofurancarboxylic acid, 5-methyl-

Description:

2-Benzofurancarboxylic acid, 5-methyl- is an organic compound characterized by its fused benzofuran structure, which consists of a benzene ring fused to a furan ring, with a carboxylic acid functional group and a methyl group at the 5-position of the furan. This compound typically appears as a solid at room temperature and is soluble in organic solvents. It exhibits acidic properties due to the presence of the carboxylic acid group, allowing it to participate in various chemical reactions, such as esterification and amidation. The presence of the methyl group can influence its reactivity and physical properties, including melting and boiling points. Additionally, compounds of this type may have applications in pharmaceuticals, agrochemicals, or as intermediates in organic synthesis. Its unique structure may also impart specific biological activities, making it of interest in medicinal chemistry. As with many organic compounds, safety data should be consulted to understand its handling and potential hazards.

Formula: C₁₀H₈O₃

2-Benzofurancarboxylic acid, 5-methyl-

CAS: 10242-09-8

Formula: C₁₀H₈O₃

Purity: 97%

Color and Shape: Solid

Molecular weight: 176.1687

Ref: IN-DA0007FH

5-Methylbenzofuran-2-carboxylic acid

CAS: 10242-09-8

5-Methylbenzofuran-2-carboxylic acid

Purity: 95%

Molecular weight: 176.17g/mol

Ref: 54-OR346652

5-Methylbenzofuran-2-carboxylic acid

CAS: 10242-09-8

Formula: C₁₀H₈O₃

Purity: 97%

Color and Shape: Solid

Molecular weight: 176.171

Ref: 10-F232586

5-Methylbenzofuran-2-carboxylic acid

CAS: 10242-09-8

5-Methylbenzofuran-2-carboxylic acid is a ligand that binds to the hydroxamic acid site on histone deacetylases, which are enzymes that remove acetyl groups from lysine residues on histones. This causes histones to become tightly packed, which inhibits transcription of DNA into RNA (gene expression). 5-Methylbenzofuran-2-carboxylic acid has been shown to be an inhibitor of the tumor growth and metastasis in animal models. The efficiencies of this drug in inhibiting the histone deacetylase enzyme have been found to be minimal. However, it is thought that this drug may be effective in combination with other drugs as a therapeutic agent for cancer treatment.

Formula: C₁₀H₈O₃

Purity: Min. 95%

Molecular weight: 176.17 g/mol

Ref: 3D-KAA24209